Hepatic deletion of serine palmitoyl transferase 2 impairs ceramide/sphingomyelin balance, bile acids homeostasis and leads to liver damage in mice - Centre de recherche des Cordeliers Access content directly
Journal Articles Biochimica et Biophysica Acta Molecular and Cell Biology of Lipids Year : 2023

Hepatic deletion of serine palmitoyl transferase 2 impairs ceramide/sphingomyelin balance, bile acids homeostasis and leads to liver damage in mice

Abstract

Ceramides (Cer) have been shown as lipotoxic inducers, which disturb numerous cell-signaling pathways, leading to metabolic disorders such as type 2 diabetes. In this study, we aimed to determine the role of de novo hepatic ceramide synthesis in energy and liver homeostasis in mice. We generated mice lacking serine palmitoyltransferase 2 (Sptlc2), the rate limiting enzyme of ceramide de novo synthesis, in liver under albumin promoter. Liver function, glucose homeostasis, bile acid (BA) metabolism and hepatic sphingolipids content were assessed using metabolic tests and LC-MS. Despite lower expression of hepatic Sptlc2, we observed an increased concentration of hepatic Cer, associated with a 10-fold increase in neutral sphingomyelinase 2 (nSMase2) expression, and a decreased sphingomyelin content in the liver. Sptlc2ΔLiv mice were protected against obesity induced by high fat diet and displayed a defect in lipid absorption. In addition, an important increase in tauro-muricholic acid was associated with a downregulation of the nuclear BA receptor FXR target genes. Sptlc2 deficiency also enhanced glucose tolerance and attenuated hepatic glucose production, while the latter effect was dampened in presence of nSMase2 inhibitor. Finally, Sptlc2 disruption promoted apoptosis, inflammation and progressive development of hepatic fibrosis, worsening with age. Our data suggest a compensatory mechanism to regulate hepatic ceramides content from sphingomyelin hydrolysis, with deleterious impact on liver homeostasis. In addition, our results show the involvement of hepatic sphingolipid modulation in BA metabolism and hepatic glucose production in an insulin-independent manner, which highlight the still under-researched role of ceramides in many metabolic functions.
Fichier principal
Vignette du fichier
2023_Lallement_BBA.pdf (10.7 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive
licence : CC BY NC ND - Attribution - NonCommercial - NoDerivatives

Dates and versions

hal-04282229 , version 1 (14-11-2023)

Licence

Attribution - NoDerivatives

Identifiers

Cite

Justine Lallement, Ilyès Raho, Grégory Merlen, Dominique Rainteau, Mikael Croyal, et al.. Hepatic deletion of serine palmitoyl transferase 2 impairs ceramide/sphingomyelin balance, bile acids homeostasis and leads to liver damage in mice. Biochimica et Biophysica Acta Molecular and Cell Biology of Lipids, 2023, 1868 (8), pp.1-13. ⟨10.1016/j.bbalip.2023.159333⟩. ⟨hal-04282229⟩
32 View
11 Download

Altmetric

Share

Gmail Facebook X LinkedIn More